[Management of coronary heart disease: seasonal features].
Atenolol was tested for its effect on the fatty acid spectrum of serum low-density lipoproteins in patients with coronary heart disease in winter and summer. There was a significant increase in saturated fatty acids and a reduction in unsaturated fatty acids during treatment.